| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-04 06:39:11 UTC |
|---|
| Updated at | 2022-09-04 06:39:11 UTC |
|---|
| NP-MRD ID | NP0190052 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | [(1r,2s,10r,13s)-7,18-dimethoxy-6,17,21-trimethyl-5,8,12,16,19-pentaoxo-11,21-diazapentacyclo[11.7.1.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-4(9),6,15(20),17-tetraen-10-yl]methyl (2z)-2-methylbut-2-enoate |
|---|
| Description | (-)-Renieramycin G belongs to the class of organic compounds known as isoquinoline quinones. These are isoquinoline derivative with a structure containing a 5,8-dihydroisoquinoline-5,8-dione skeleton. [(1r,2s,10r,13s)-7,18-dimethoxy-6,17,21-trimethyl-5,8,12,16,19-pentaoxo-11,21-diazapentacyclo[11.7.1.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-4(9),6,15(20),17-tetraen-10-yl]methyl (2z)-2-methylbut-2-enoate was first documented in 2006 (PMID: 16632360). Based on a literature review a small amount of articles have been published on (-)-renieramycin G (PMID: 32437173) (PMID: 24473157) (PMID: 33300542) (PMID: 21295980). |
|---|
| Structure | COC1=C(C)C(=O)C2=C([C@H](COC(=O)C(\C)=C/C)N3[C@@H](C2)[C@@H]2N(C)[C@@H](CC4=C2C(=O)C(OC)=C(C)C4=O)C3=O)C1=O InChI=1S/C30H32N2O9/c1-8-12(2)30(38)41-11-19-20-15(23(33)13(3)27(39-6)25(20)35)9-17-22-21-16(10-18(31(22)5)29(37)32(17)19)24(34)14(4)28(40-7)26(21)36/h8,17-19,22H,9-11H2,1-7H3/b12-8-/t17-,18-,19-,22-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Renieramycin g | MeSH |
|
|---|
| Chemical Formula | C30H32N2O9 |
|---|
| Average Mass | 564.5910 Da |
|---|
| Monoisotopic Mass | 564.21078 Da |
|---|
| IUPAC Name | [(1R,2S,10R,13S)-7,18-dimethoxy-6,17,21-trimethyl-5,8,12,16,19-pentaoxo-11,21-diazapentacyclo[11.7.1.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-4(9),6,15(20),17-tetraen-10-yl]methyl (2Z)-2-methylbut-2-enoate |
|---|
| Traditional Name | [(1R,2S,10R,13S)-7,18-dimethoxy-6,17,21-trimethyl-5,8,12,16,19-pentaoxo-11,21-diazapentacyclo[11.7.1.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-4(9),6,15(20),17-tetraen-10-yl]methyl (2Z)-2-methylbut-2-enoate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | COC1=C(C)C(=O)C2=C([C@H](COC(=O)C(\C)=C/C)N3[C@@H](C2)[C@@H]2N(C)[C@@H](CC4=C2C(=O)C(OC)=C(C)C4=O)C3=O)C1=O |
|---|
| InChI Identifier | InChI=1S/C30H32N2O9/c1-8-12(2)30(38)41-11-19-20-15(23(33)13(3)27(39-6)25(20)35)9-17-22-21-16(10-18(31(22)5)29(37)32(17)19)24(34)14(4)28(40-7)26(21)36/h8,17-19,22H,9-11H2,1-7H3/b12-8-/t17-,18-,19-,22-/m0/s1 |
|---|
| InChI Key | IECPOXKFSCFJHH-XEQTUUQBSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as isoquinoline quinones. These are isoquinoline derivative with a structure containing a 5,8-dihydroisoquinoline-5,8-dione skeleton. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Isoquinolines and derivatives |
|---|
| Sub Class | Isoquinoline quinones |
|---|
| Direct Parent | Isoquinoline quinones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Isoquinoline quinone
- Isoquinolone
- Alpha-amino acid or derivatives
- Fatty acid ester
- N-methylpiperazine
- N-alkylpiperazine
- 1,4-diazinane
- Fatty acyl
- Piperazine
- Vinylogous ester
- Tertiary carboxylic acid amide
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- Tertiary amine
- Amino acid or derivatives
- Tertiary aliphatic amine
- Carboxamide group
- Lactam
- Ketone
- Carboxylic acid ester
- Monocarboxylic acid or derivatives
- Azacycle
- Carboxylic acid derivative
- Amine
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organonitrogen compound
- Carbonyl group
- Organic nitrogen compound
- Organooxygen compound
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Zheng Y, Li XD, Sheng PZ, Yang HD, Wei K, Yang YR: Asymmetric Total Syntheses of (-)-Fennebricin A, (-)-Renieramycin J, (-)-Renieramycin G, (-)-Renieramycin M, and (-)- Jorunnamycin A via C-H Activation. Org Lett. 2020 Jun 5;22(11):4489-4493. doi: 10.1021/acs.orglett.0c01493. Epub 2020 May 21. [PubMed:32437173 ]
- Lane JW, Estevez A, Mortara K, Callan O, Spencer JR, Williams RM: Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G. Bioorg Med Chem Lett. 2006 Jun 15;16(12):3180-3. doi: 10.1016/j.bmcl.2006.03.042. Epub 2006 May 2. [PubMed:16632360 ]
- Liu H, Chen R, Chen X: A rapid and efficient access to renieramycin-type alkaloids featuring a temperature-dependent stereoselective cyclization. Org Biomol Chem. 2014 Mar 14;12(10):1633-40. doi: 10.1039/c3ob42209g. [PubMed:24473157 ]
- Ma Y, Pan X, Guan B, Zhang G, Liu Z: Synthesis and cytotoxicity of (-)-homo-renieramycin G and its derivatives. Org Biomol Chem. 2020 Dec 28;18(48):9883-9894. doi: 10.1039/d0ob02167a. Epub 2020 Dec 10. [PubMed:33300542 ]
- Liu W, Dong W, Liao X, Yan Z, Guan B, Wang N, Liu Z: Synthesis and cytotoxicity of (-)-renieramycin G analogs. Bioorg Med Chem Lett. 2011 Mar 1;21(5):1419-21. doi: 10.1016/j.bmcl.2011.01.025. Epub 2011 Jan 11. [PubMed:21295980 ]
- LOTUS database [Link]
|
|---|